Literature DB >> 24510120

The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder.

M Gierth1, A Aziz, H M Fritsche, M Burger, W Otto, F Zeman, M T Pawlik, E Hansen, M May, S Denzinger.   

Abstract

PURPOSE: Radical cystectomy (RC) can be associated with significant blood loss. Allogenic blood transfusion (ABT) may alter disease outcome because of a theoretical immunomodulatory effect. We evaluated the effects of ABT on overall survival (OS) and progression-free survival (PFS) of patients undergoing RC for urothelial carcinoma of the bladder (UCB).
MATERIALS AND METHODS: This is a retrospective single-center study of 350 consecutive patients of a university health center with a median follow-up of 70.1 month. All patients underwent RC and pelvic lymph node dissection. The effect of ABT on OS and PFS was analyzed using univariable and multivariable Cox proportional hazards models.
RESULTS: The overall ABT rate was 63 % (n = 219), with intraoperative blood transfusion and postoperative blood transfusion being performed in 183 patients (52 %) and 99 patients (28 %), respectively. Preoperative anemia was detected in 156 patients (45 %) with median estimated blood loss of 800 ml (IQR: 500-1,200). ABT was associated with significant decrease of OS and PFS in multivariable analyses (p < 0.001), whereas patients' prognosis worsened the more packed red blood cells (PRBC) were transfused (p < 0.001). The study is limited in part due to its retrospective design.
CONCLUSIONS: We found that ABT and the number of PRBC transfused are associated with poor prognosis for UCB patients undergoing RC, whereas preoperative anemia had no influence on survival. This emphasizes the importance of surgeon's awareness for a strict indication for ABT. A prospective study will be necessary to evaluate the independent risks associated with ABT during surgical treatments.

Entities:  

Mesh:

Year:  2014        PMID: 24510120     DOI: 10.1007/s00345-014-1257-x

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  25 in total

1.  Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery.

Authors:  L L Pisters; Z Wajsman
Journal:  Urology       Date:  1992-09       Impact factor: 2.649

2.  Identifying risk factors for potentially avoidable complications following radical cystectomy.

Authors:  Brent K Hollenbeck; David C Miller; David Taub; Rodney L Dunn; Shukri F Khuri; William G Henderson; James E Montie; Willie Underwood; John T Wei
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

3.  Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.

Authors:  Roman Mayr; Matthias May; Thomas Martini; Michele Lodde; Armin Pycha; Evi Comploj; Wolf F Wieland; Stefan Denzinger; Wolfgang Otto; Maximilian Burger; Hans-Martin Fritsche
Journal:  BJU Int       Date:  2012-02-07       Impact factor: 5.588

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Red blood cells for cancer patients.

Authors:  C L Gantt
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

6.  Intra-operative autotransfusion in radical cystectomy.

Authors:  K I Park; O Kojima; T Tomoyoshi
Journal:  Br J Urol       Date:  1997-05

7.  The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.

Authors:  Todd M Morgan; Daniel A Barocas; Sam S Chang; Sharon E Phillips; Shady Salem; Peter E Clark; David F Penson; Joseph A Smith; Michael S Cookson
Journal:  Urol Oncol       Date:  2011-09-09       Impact factor: 3.498

8.  Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer.

Authors:  Mario Nosotti; Paolo Rebulla; Donatella Riccardi; Alessandro Baisi; Nadia Bellaviti; Lorenzo Rosso; Luigi Santambrogio
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

9.  Does the presence of significant risk factors affect perioperative outcomes after robot-assisted radical cystectomy?

Authors:  Zubair M Butt; Anees Fazili; Wei Tan; Gregory E Wilding; Victor Filadora; Hyung L Kim; James L Mohler; Kathleen A O'Leary; Khurshid A Guru
Journal:  BJU Int       Date:  2009-06-22       Impact factor: 5.588

10.  Perioperative blood transfusion has prognostic significance for breast cancer.

Authors:  P I Tartter; L Burrows; A E Papatestas; G Lesnick; A H Aufses
Journal:  Surgery       Date:  1985-02       Impact factor: 3.982

View more
  9 in total

1.  Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.

Authors:  M Gierth; R Mayr; A Aziz; S Krieger; B Wullich; A Pycha; M Lodde; U Salvadori; J Bründl; H M Fritsche; F Hofstädter; M T Pawlik; W Otto; M May; M Burger; S Denzinger
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-02       Impact factor: 4.553

Review 2.  Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.

Authors:  Karthik Tanneru; Seyed Behzad Jazayeri; Jatinder Kumar; Muhammad Umar Alam; Daniel Norez; Sabine Nguyen; Soroush Bazargani; Hariharan Palayapalayam Ganapathi; Mark Bandyk; Robert Marino; Shahriar Koochekpour; Shiva Gautam; K C Balaji; Joseph Costa
Journal:  J Robot Surg       Date:  2020-11-22

3.  Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study.

Authors:  Louis Lenfant; Gregory Verhoest; Riccardo Campi; Jérôme Parra; Vivien Graffeille; Alexandra Masson-Lecomte; Dimitri Vordos; Alexandre de La Taille; Mathieu Roumiguie; Marine Lesourd; Lionel Taksin; Vincent Misraï; Pietro Grande; Christophe Vaessen; Guillaume Ploussard; Benjamin Granger; Morgan Rouprêt
Journal:  World J Urol       Date:  2018-05-09       Impact factor: 4.226

Review 4.  Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis.

Authors:  You-Lin Wang; Bo Jiang; Fu-Fen Yin; Hao-Qing Shi; Xiao-Dong Xu; Shuai-Shuai Zheng; Shuai Wu; Si-Chuan Hou
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

5.  The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy.

Authors:  Joong Sub Lee; Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2015-03-26

Review 6.  Impact of perioperative blood transfusions on clinical outcomes in patients undergoing surgery for major urologic malignancies.

Authors:  Yasmin Abu-Ghanem; Jacob Ramon
Journal:  Ther Adv Urol       Date:  2019-08-12

Review 7.  Prognostic impact of perioperative blood transfusions on oncological outcomes of patients with bladder cancer undergoing radical cystectomy: A systematic review.

Authors:  Yannic Volz; Lennert Eismann; Paulo L Pfitzinger; Jan-Friedrich Jokisch; Alexander Buchner; Boris Schlenker; Christian G Stief; Gerald B Schulz
Journal:  Arab J Urol       Date:  2020-12-10

Review 8.  Impact of Transfusion on Cancer Growth and Outcome.

Authors:  Hadi A Goubran; Mohamed Elemary; Miryana Radosevich; Jerard Seghatchian; Magdy El-Ekiaby; Thierry Burnouf
Journal:  Cancer Growth Metastasis       Date:  2016-03-13

9.  A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy.

Authors:  Gustaf Klinga; Amir Sherif
Journal:  Springerplus       Date:  2016-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.